Prevalence And Excess Risk Of Hospitalization In Heart Failure With Reduced Ejection Fraction
Desai N, Butler J, Binder G, Greene S. Prevalence And Excess Risk Of Hospitalization In Heart Failure With Reduced Ejection Fraction. Journal Of Cardiac Failure 2023, 29: 641. DOI: 10.1016/j.cardfail.2022.10.232.Peer-Reviewed Original ResearchHF hospitalizationReduced ejection fractionHeart failureEjection fractionHF populationExcess riskRisk factorsAverage patientAdult HF patientsHF hospitalization ratesPrevalence of HFHeart failure hospitalizationHigh-risk subgroupsHigh-risk groupNew treatment optionsFailure hospitalizationHF patientsCardiovascular deathAdult patientsConclusions PatientsHospitalization riskHospitalization ratesHF eventsTreatment optionsUS prevalenceClinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States
Desai N, Sutton M, Xie J, Fine J, Gao W, Owens A, Naidu S. Clinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States. The American Journal Of Cardiology 2023, 192: 16-23. PMID: 36709525, DOI: 10.1016/j.amjcard.2022.12.030.Peer-Reviewed Original ResearchConceptsObstructive hypertrophic cardiomyopathyHypertrophic cardiomyopathyIndex dateCardiovascular eventsIncidence rateSymptomatic obstructive hypertrophic cardiomyopathyAtrial fibrillation/flutterCommon cardiovascular eventMonths continuous eligibilityHealthcare resource utilizationMedicare Supplemental databasesIBM MarketScan CommercialEligible patientsDiagnosis dateMarketScan CommercialClinical outcomesContinuous eligibilityTreatment optionsCumulative riskPatientsResource utilizationPharmacotherapyCardiomyopathyDisease